Evidence map›Paper›PMID 33832973›Full record

ArticlemBio2021

Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children.

Michael J Bale, Mary Grace Katusiime, Daria Wells, Xiaolin Wu, Jonathan Spindler, Elias K Halvas, Joshua C Cyktor, Ann Wiegand, Wei Shao, Mark F Cotton and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Michael J Bale *HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
Mary Grace Katusiime *HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA marygrace.katusiime@nih.gov.
Daria WellsLeidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Xiaolin WuLeidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Jonathan SpindlerHIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
Elias K HalvasDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Joshua C CyktorDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Ann WiegandHIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
Wei ShaoLeidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Mark F CottonDepartment of Pediatrics and Child Health, Tygerberg Children's Hospital and Family Center for Research with Ubuntu, Stellenbosch University, Cape Town, South Africa.
Stephen H HughesHIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.ORCID 0000-0002-9176-4377
John W MellorsDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
John M CoffinDepartment of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
Gert U Van ZylDivision of Medical Virology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town, South Africa.
Mary F KearneyHIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, Maryland, USA.
National Cancer Institute · USLeidos (United States) · USUniversity of Pittsburgh · USNational Health Laboratory Service · ZAStellenbosch University · ZATufts University · US

Funding

IntegraseZIABC011426 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HUGHES, STEPHEN H · 2012 to 2022
$14.0M
Retrovirus Evolution and CancerR35CA200421 · NCI · TUFTS UNIVERSITY BOSTON · PI COFFIN, JOHN M · 2016 to 2022
$6.5M
Quantify the Fraction of Proviruses That Express HIV RNA to Better Understand Proviral Latency and Its ReversalZIABC011698 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2025
$5.1M
Latent reservoir characterization and correlations with neurocognitive functioninR01MH105134 · NIMH · STELLENBOSCH UNIVERSITY · PI COTTON, MARK FREDRIC · 2014 to 2018
$3.1M
Characterizing HIV-1 diversity, evolution, and integration sites in children initiating cART in early infectionU01CA200441 · NCI · STELLENBOSCH UNIVERSITY · PI KEARNEY, MARY, VAN ZYL, GERT UVES · 2015 to 2019
$842k
NCI NIH HHS R35 CA200421NCI NIH HHS U01 CA200441NIMH NIH HHS R01 MH105134
6 · The paper itself

Abstract

Little is known about the emergence and persistence of human immunodeficiency virus (HIV)-infected T-cell clones in perinatally infected children. We analyzed peripheral blood mononuclear cells (PBMCs) for clonal expansion in 11 children who initiated antiretroviral therapy (ART) between 1.8 and 17.4 months of age and with viremia suppressed for 6 to 9 years. We obtained 8,662 HIV type 1 (HIV-1) integration sites from pre-ART samples and 1,861 sites from on-ART samples. Expanded clones of infected cells were detected pre-ART in 10/11 children. In 8 children, infected cell clones detected pre-ART persisted for 6 to 9 years on ART. A comparison of integration sites in the samples obtained on ART with healthy donor PBMCs infected

Indexed as

Virus IntegrationAnti-Retroviral AgentsCD4-Positive T-LymphocytesChildClinical Trials, Phase III as TopicDNA, ViralFemaleHIV-1HIV InfectionsHumansMaleProvirusesRandomized Controlled Trials as TopicTime FactorsT-LymphocytesViral LoadAnti-Retroviral AgentsDNA, Viralclonal expansionHIV infectionintegration site analysisperinatal infection

Identifiers

PMID33832973
PMCPMC8092253
OpenAlexW3143105578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.